XML 42 R5.htm IDEA: XBRL DOCUMENT v3.26.1
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Series C Preferred Stock
Common Stock
Common Stock
IPO
Additional Paid-In Capital
Additional Paid-In Capital
IPO
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Temporary equity beginning balance at Dec. 31, 2023   $ 43,904              
Temporary equity beginning balance, shares at Dec. 31, 2023   48,910,723              
Beginning balance at Dec. 31, 2023 $ (34,802)     $ 0   $ 2,937   $ 0 $ (37,739)
Outstanding Beginning balance, shares at Dec. 31, 2023       3,966,376          
Issuance of Series C convertible preferred stock for cash, net of issuance cost of $2,148     $ 82,852            
Issuance of Series C convertible preferred stock for cash, net of issuance cost of $2,148, shares     48,030,730            
Exercise of common stock options 300         300      
Exercise of common stock options, shares       96,786          
Vesting of restricted common stock 8         8      
Vesting of restricted common stock, shares       3,807          
Stock-based compensation expense 439         439      
Net Income (Loss) (20,588)               (20,588)
Temporary equity ending balance at Dec. 31, 2024 $ 126,756 $ 126,756              
Temporary equity ending balance, shares at Dec. 31, 2024 96,941,453 96,941,453              
Ending balance at Dec. 31, 2024 $ (54,643)     $ 0   3,684   0 (58,327)
Outstanding Ending balance, shares at Dec. 31, 2024       4,066,969          
Issuance of common stock in initial public offering, net of discounts and issuance costs of $10.4 million 87,495           $ 87,495    
Issuance of common stock in initial public offering, net of discounts and issuance costs of $10.4 million, shares         6,120,661        
Temporary Equity conversion of convertible preferred stock into common stock upon initial public offering   $ (126,756)              
Temporary Equity conversion of convertible preferred stock into common stock upon initial public offering, shares   (96,941,453)              
Conversion of convertible preferred stock into common stock upon initial public offering 126,756         126,756      
Conversion of convertible preferred stock into common stock upon initial public offering, shares       11,439,838          
Exercise of common stock options $ 355         355      
Exercise of common stock options, shares 2,950     146,926          
Vesting of restricted common stock $ 37         37      
Vesting of restricted common stock, shares 11,367     11,367          
Issuance of common stock under employee stock purchase plan, shares       29,592          
Issuance of common stock under employee stock purchase plan $ 195         195      
Stock-based compensation expense 3,948         3,948      
Unrealized gain on short-term investments 81             81  
Net Income (Loss) (57,591)               (57,591)
Temporary equity ending balance at Dec. 31, 2025 $ 0 $ 0              
Temporary equity ending balance, shares at Dec. 31, 2025 0 0              
Ending balance at Dec. 31, 2025 $ 106,633     $ 0   $ 222,470   $ 81 $ (115,918)
Outstanding Ending balance, shares at Dec. 31, 2025       21,815,353